Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Boffito

Showing results (1-10 of 300) with videos related to

Pageof 30
Sort By:
The New Microbiologica|September 7, 2007
Pharmacokinetics and pharmacodynamics in HAART and antibiotic therapyMarta Boffito
Current Opinion in HIV and AIDS|May 26, 2018
Rilpivirine long-acting for the prevention and treatment of HIV infectionFrancesca Ferretti, Marta Boffito
The Lancet. HIV|May 27, 2017
Long-acting cabotegravir for prevention: hope versus realitySheena McCormack, Marta Boffito
The Journal of Antimicrobial Chemotherapy|June 9, 2005
The management of HIV-1 protease inhibitor pharmacokinetic interactionsAlan Winston, Marta Boffito
British Journal of Clinical Pharmacology|March 26, 2008
A review of the clinical pharmacology of maraviroc. IntroductionMarta Boffito, Samantha Abel
Lancet (London, England)|July 6, 2004
Unexpected drug interactions and adverse events with antiretroviral drugsGraeme Moyle, Marta Boffito
The Lancet. HIV|October 16, 2021
More evidence for worse COVID-19 outcomes in people with HIVMarta Boffito, Laura Waters
The Lancet. HIV|January 9, 2023
Update on injectable antiretrovirals at HIV GlasgowLaura Waters, Marta Boffito
Clinical Pharmacokinetics|March 4, 2015
Authors' reply: pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptivesNneka Nwokolo, Marta Boffito
Lancet (London, England)|September 5, 2017
The triumph of HIV treatment: another new antiretroviralMarta Boffito, Francois Venter
Pageof 30

Showing results (1-10 of 300) with videos related to

Sort By:
Pageof 30
The New Microbiologica|September 7, 2007
Pharmacokinetics and pharmacodynamics in HAART and antibiotic therapyMarta Boffito
Current Opinion in HIV and AIDS|May 26, 2018
Rilpivirine long-acting for the prevention and treatment of HIV infectionFrancesca Ferretti, Marta Boffito
The Lancet. HIV|May 27, 2017
Long-acting cabotegravir for prevention: hope versus realitySheena McCormack, Marta Boffito
The Journal of Antimicrobial Chemotherapy|June 9, 2005
The management of HIV-1 protease inhibitor pharmacokinetic interactionsAlan Winston, Marta Boffito
British Journal of Clinical Pharmacology|March 26, 2008
A review of the clinical pharmacology of maraviroc. IntroductionMarta Boffito, Samantha Abel
Lancet (London, England)|July 6, 2004
Unexpected drug interactions and adverse events with antiretroviral drugsGraeme Moyle, Marta Boffito
The Lancet. HIV|October 16, 2021
More evidence for worse COVID-19 outcomes in people with HIVMarta Boffito, Laura Waters
The Lancet. HIV|January 9, 2023
Update on injectable antiretrovirals at HIV GlasgowLaura Waters, Marta Boffito
Clinical Pharmacokinetics|March 4, 2015
Authors' reply: pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptivesNneka Nwokolo, Marta Boffito
Lancet (London, England)|September 5, 2017
The triumph of HIV treatment: another new antiretroviralMarta Boffito, Francois Venter
Pageof 30